GAO To TRICARE: Align Regulations With Compounded Drug Pay Policy

The Government Accountability Office last week said the Department of Defense's coverage of some compounded drugs containing bulk ingredients under the Tricare program sways from DOD's regulatory policy and called for the department to better align its regulations with its payment practices -- possibly by allowing payments for some bulk drug ingredients. The recommendation comes as compounders are fending off coverage restrictions stemming from the increasing cost of bulk ingredients, with some stakeholders viewing the report as favorable to the...